Home › Stocks › NAMSW

NAMSW — NEWAMSTERDAM PHARMA COMPANY

Reported value held$33.03M
Funds holding (latest)24
SectorMaterials

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)11
Institutional value$31.30M · 1.46M sh
New / Add / Cut / Exit0 / 2 / 0 / 0 · Updated 2026-11-14
Top-5 / Top-10 concentration87.2% / 100.0%
Institutional holdings change Accumulating +0.9% (+12.85K sh)
Institutional value change Up +7.9%

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 11 SEC-registered investment managers reported holding NAMSW (NEWAMSTERDAM PHARMA COMPANY) in their latest 13F filings, with a combined reported value of $31.30M across 1.46M shares. That is +0.9% by share count (+12.85K shares) versus the previous quarter, while reported value moved +7.9%. Ownership is concentrated: the five largest holders account for 87.2% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 2 added to existing stakes. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

Major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMSW) include Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., Affinity Asset Advisors, LLC, ranked by reported 13F value among the 24 institutional holders on this page.

NAMSW is classified in the Materials sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 4 269.57K $3.63M +1.0%
Q2 2026 11 1.46M $31.30M +0.9%
Q1 2026 11 1.45M $29.01M -0.2%
Q4 2025 10 1.45M $33.34M -0.0%
Q3 2025 10 1.45M $24.78M -0.0%
Q2 2025 11 1.45M $11.61M -0.4%
Q1 2025 11 1.46M $13.66M +0.0%
Q4 2024 12 1.47M $20.88M +0.8%

Over the 8 quarters shown, institutional share counts decreased 82% in aggregate (Q4 2024 → Q3 2026).

Top Institutional Holders (Q3 2026) — 4 funds

FundSharesValuePortfolio WeightChange
Affinity Asset Advisors, LLC 245.00K $3.31M 0.15% Hold
WOLVERINE ASSET MANAGEMENT LLC 17.46K $220.92K 0.00% Add
Vestcor Inc 6.67K $103.00K 0.00% Hold
UBS Group AG 443 $5.75K 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 11 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 500.33K $10.69M 0.23% Hold
RA CAPITAL MANAGEMENT, L.P. 333.33K $7.12M 0.06% Hold
Affinity Asset Advisors, LLC 245.00K $5.34M 0.26% Hold
Bain Capital Life Sciences Investors, LLC history 100.00K $2.14M 0.13% Hold
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $1.98M 0.03% Hold
Millennium Management 75.00K $1.60M 0.00% Hold
MILLENNIUM MANAGEMENT LLC 75.00K $1.60M 0.00% Hold
ARISTEIA CAPITAL, L.L.C. 15.71K $343.38K 0.01% Hold
WOLVERINE ASSET MANAGEMENT LLC 14.93K $318.95K 0.01% Add
Vestcor Inc 6.67K $143.00K 0.00% Hold
UBS Group AG 443 $8.52K 0.00% Add

Q1 2026 — 11 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 500.33K $10.03M 0.26% Hold
RA CAPITAL MANAGEMENT, L.P. 333.33K $6.68M 0.07% Hold
Affinity Asset Advisors, LLC 245.00K $4.91M 0.26% Hold
Bain Capital Life Sciences Investors, LLC history 100.00K $2.00M 0.18% Hold
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $1.86M 0.03% Hold
Millennium Management 75.00K $1.50M 0.00% Hold
MILLENNIUM MANAGEMENT LLC 75.00K $1.50M 0.00% Hold
ARISTEIA CAPITAL, L.L.C. 15.71K $342.67K 0.01% Hold
Vestcor Inc 6.67K $131.00K 0.00% Reduce
WOLVERINE ASSET MANAGEMENT LLC 2.13K $42.62K 0.00% New
UBS Group AG 396 $7.94K 0.00% Hold

Q4 2025 — 10 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 500.33K $11.51M 0.31% Hold
RA CAPITAL MANAGEMENT, L.P. 333.33K $7.67M 0.08% Hold
Affinity Asset Advisors, LLC 245.00K $5.63M 0.34% Hold
Bain Capital Life Sciences Investors, LLC history 100.00K $2.30M 0.18% Hold
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $2.13M 0.03% Hold
Millennium Management 75.00K $1.73M 0.00% Hold
MILLENNIUM MANAGEMENT LLC 75.00K $1.73M 0.00% Hold
ARISTEIA CAPITAL, L.L.C. 15.71K $397.02K 0.01% New
Vestcor Inc 9.63K $239.00K 0.01% Hold
UBS Group AG 396 $9.27K 0.00% Reduce

Q3 2025 — 10 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 500.33K $8.56M 0.26% Hold
RA CAPITAL MANAGEMENT, L.P. 333.33K $5.70M 0.07% Hold
Affinity Asset Advisors, LLC 245.00K $4.19M 0.40% Hold
Bain Capital Life Sciences Investors, LLC history 100.00K $1.71M 0.11% Hold
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $1.59M 0.03% Hold
MILLENNIUM MANAGEMENT LLC 75.00K $1.28M 0.00% Hold
Millennium Management 75.00K $1.28M 0.00% Hold
Laurion Capital Management LP 16.67K $285.15K 0.01% Hold
Vestcor Inc 9.63K $165.00K 0.01% Hold
UBS Group AG 512 $8.76K 0.00% Reduce

Q2 2025 — 11 funds

FundSharesValuePortfolio WeightChange
Frazier Life Sciences Management, L.P. history 500.33K $4.00M 0.16% Hold
RA CAPITAL MANAGEMENT, L.P. 333.33K $2.67M 0.04% Hold
Affinity Asset Advisors, LLC 245.00K $1.96M 0.30% Add
Bain Capital Life Sciences Investors, LLC history 100.00K $800.00K 0.10% Hold
DEERFIELD MANAGEMENT COMPANY, L.P. 92.79K $742.30K 0.01% Hold
MILLENNIUM MANAGEMENT LLC 75.00K $600.00K 0.00% Hold
Millennium Management 75.00K $600.00K 0.00% Hold
Laurion Capital Management LP 16.67K $133.33K 0.01% Hold
Vestcor Inc 9.63K $77.00K 0.00% Hold
WOLVERINE ASSET MANAGEMENT LLC 2.09K $16.73K 0.00% Reduce
UBS Group AG 993 $7.94K 0.00% Reduce

New Positions (Q2 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Affinity Asset Advisors, LLC 245.00K 245.00K 245.00K 245.00K 245.00K 245.00K 241.96K 237.94K 212.97K 202.60K 202.60K 137.00K 137.00K — — —
WOLVERINE ASSET MANAGEMENT LLC 17.46K 14.93K 2.13K — — 2.09K 8.88K 12.69K — — — — — — — —
Vestcor Inc 6.67K 6.67K 6.67K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K 9.63K — — —
UBS Group AG 443 443 396 396 512 993 2.38K 2.48K — — — — 38 — — 1.08K
Frazier Life Sciences Management, L.P. — 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K 500.33K — — —
RA CAPITAL MANAGEMENT, L.P. — 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K 333.33K — — —
Bain Capital Life Sciences Investors, LLC — 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K 100.00K — — —
DEERFIELD MANAGEMENT COMPANY, L.P. — 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K 92.79K — — —
Millennium Management — 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K
MILLENNIUM MANAGEMENT LLC — 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K 75.00K — — —
GTS SECURITIES LLC — — — — — — — — — — 121.15K — — — — —
EcoR1 Capital, LLC — — — — — — — — — — — 66.67K 66.67K — — —
Ensign Peak Advisors, Inc — — — — — — — — — — — 150.00K 150.00K — — —
ARISTEIA CAPITAL, L.L.C. — 15.71K 15.71K 15.71K — — — — — — — — — — — —
Monashee Investment Management LLC — — — — — — — — 31.19K — 31.19K — — — — —
HRT FINANCIAL LP — — — — — — — 13.65K 27.12K 30.32K 30.32K 30.32K 30.32K — — —
Laurion Capital Management LP — — — — 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K 16.67K — — —
ADAR1 Capital Management, LLC — — — — — — — — — — — 82.86K — — — —
Westchester Capital Management, LLC — — — — — — — — — — — 31.19K 31.19K — — —
HIGHBRIDGE CAPITAL MANAGEMENT LLC — — — — — — — — — — — — 54.18K — — —

Download holders (CSV)

FAQ

Which funds hold NAMSW?

As of 2026-Q2, 11 institutional funds reported holding NAMSW (NEWAMSTERDAM PHARMA COMPANY) in SEC 13F filings, with a combined reported value of $31.30M.

How many shares of NAMSW do institutions own?

13F filers reported 1.46M shares of NAMSW, worth $31.30M in aggregate at the end of 2026-Q2.

Is institutional ownership of NAMSW rising or falling?

Share counts moved +0.9% versus the prior quarter — accumulation.

Who are the top institutional holders of NAMSW?

The largest 13F holders are Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., Affinity Asset Advisors, LLC, Bain Capital Life Sciences Investors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P.; the top 25 are ranked at the top of this page.

Who are the major shareholders of NEWAMSTERDAM PHARMA COMPANY?

The major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMSW) by reported 13F value are Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., Affinity Asset Advisors, LLC, Bain Capital Life Sciences Investors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 24 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own NAMSW" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/NAMSW/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →